US75973T1016 - ADR
RENALYTIX AI PLC-ADR
NASDAQ:RNLX (4/24/2024, 7:26:37 PM)
After market: 0.6362 +0 (+0.06%)0.6358
-0.06 (-9.11%)
Renalytix Plc manufactures medical devices and equipment. The firm is engaged in a field of bioprognosis for kidney health. The firm has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. The company is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
RENALYTIX AI PLC-ADR
Finsgate, 5-7 Cranwood Street
London SOUTH GLAMORGAN CF64 2EZ
P: 442920710570
CEO: James McCullough
Employees: 80
Website: https://renalytix.com/
LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary...
If you can accept the wild price action, these stocks under $1 may have the goods to launch your portfolio skyward.
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk...
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!
Here you can normally see the latest stock twits on RNLX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: